Discovery of novel 1,8-naphthalimide piperazinamide based benzenesulfonamides derivatives as potent carbonic anhydrase IX inhibitors and ferroptosis inducers for the treatment of triple-negative breast cancer
- 26 June 2024
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 150, 107596
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosisArchives of Toxicology, 2023
- Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX/XII inhibitors: A new regioisomerism tacticBioorganic Chemistry, 2022
- Discovery of novel artemisinin-sulfonamide hybrids as potential carbonic anhydrase IX inhibitors with improved antiproliferative activitiesBioorganic Chemistry, 2020
- Role of carbonic anhydrases in ferroptosis-resistanceArchives of Biochemistry and Biophysics, 2020
- CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic TumorsAngewandte Chemie International Edition, 2020
- Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agentsBioorganic & Medicinal Chemistry Letters, 2020
- The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyondCancer and Metastasis Reviews, 2019
- Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of oneMedicinal Research Reviews, 2018
- Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor HypoxiaMolecular Imaging and Biology, 2015
- A Small‐Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing TumorsAngewandte Chemie International Edition, 2014